SCHEMBL28468656

SCHEMBL28468656

[CH2][C@H](O)COc1cccc(S(=O)(=O)NC)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
TNNI3K Q59H18 6/20 0.44
KAT6A Q92794 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MEP1B Q16820 1/20 0.41
EGFR P00533 1/20 0.41
TDP1 Q9NUW8 2/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28469591 0.84 PRMT5 (0.47) KAT6AL3MBTL1ALDH1A1GAAPKM
SCHEMBL21353039 0.84 PRMT5 (0.47) KAT6AL3MBTL1ALDH1A1GAAPKM
SCHEMBL28737824 0.83 PSIP1 (0.41) POLBKAT6AL3MBTL1ALDH1A1GAA
SCHEMBL28737773 0.82 KAT6A (0.42) KAT6AKDM4EHTR1DHTR1BTSHR
SCHEMBL28901422 0.81 CA1 (0.47) KAT6A
SCHEMBL28470108 0.80 CYP1A2 (0.49) POLBTNNI3KKAT6AL3MBTL1ALDH1A1
SCHEMBL28470107 0.80 CYP1A2 (0.49) POLBTNNI3KKAT6AL3MBTL1ALDH1A1
SCHEMBL14601549 0.79 KAT6A (0.52) POLBTNNI3KKAT6AL3MBTL1ALDH1A1
SCHEMBL21353640 0.77 ADRB3 (0.41) KAT6AL3MBTL1GAAMAPK1
SCHEMBL28737771 0.76 ADRB3 (0.41) KAT6AL3MBTL1ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111699189-A Modulators of beta-3 adrenergic receptors useful for the treatment or prevention of heart failure and disorders associated therewith 艾尼纳制药公司 2020-09-22 CN disclosed